Benzinga | Aug 5, 2021 06:19PM EDT

Cellectis Q2 EPS $(0.88) Misses $(0.73) Estimate, Sales $14.62M Beat $11.10M Estimate

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate of $(0.73) by 20.55 percent. This is a 29.41 percent decrease over losses of $(0.68) per share from the same period last year. The company reported quarterly sales of $14.62 million which beat the analyst consensus estimate of $11.10 million by 31.67 percent. This is a 216.62 percent increase over sales of $4.62 million the same period last year.